Back to CS Candriam S.C.A.
ORKA
7 quarters
Position history for CSCandriam S.C.A.'s holdings in Oruka Therapeutics, Inc.
Yes. Candriam S.C.A. holds 339,032 shares of ORKA (Oruka Therapeutics), worth $28.3M, as of its Q3 2026 13F filing. It reduced the position by 13,684 shares (-3.9%) from Q2 2026. Candriam S.C.A. has held ORKA since Q1 2025, across 7 quarterly 13F filings. ORKA is 0.1% of Candriam S.C.A.'s reported 13F portfolio.
Current Value
$28.3M
Current Shares
339,032
Total Value Change
+$27.1M
Total Shares Change
+222,334
Quarter-by-Quarter History